• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

drug repositioning

Biotech

Mayo Clinic helps tech-enabled R&D shop nference to $60M B round

Nference thinks its platform can help identify new targets and drug combinations by corralling existing data.
Nick Paul Taylor Jan 8, 2020 8:11am

Healx raises $56M to launch 40 rare disease R&D programs

Oct 16, 2019 3:00am

Healx reels in $10M in series A funding for work on rare diseases

Jul 27, 2018 11:17am

BTI files for $69M IPO to run trials in Alzheimer's and cancer

Feb 13, 2018 8:39am

Roivant bags AstraZeneca drug in latest bid

Oct 20, 2017 8:53am

Mayo Clinic startup raises series A round for AI-driven R&D

Jul 14, 2017 6:04am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy